• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MARVEL 结构域包含的 CMTM4 会影响 CXCR4 的转运。

MARVEL domain containing CMTM4 affects CXCR4 trafficking.

机构信息

Renal Division and.

Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, 79104 Freiburg, Germany.

出版信息

Mol Biol Cell. 2022 Nov 1;33(13):ar116. doi: 10.1091/mbc.E22-05-0152. Epub 2022 Aug 31.

DOI:10.1091/mbc.E22-05-0152
PMID:36044337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9634968/
Abstract

The MARVEL proteins CMTM4 and CMTM6 control PD-L1, thereby influencing tumor immunity. We found that defective zebrafish slowed the development of the posterior lateral line (pLL) by altering the Cxcr4b gradient across the pLL primordium (pLLP). Analysis in mammalian cells uncovered that CMTM4 interacted with CXCR4, altering its glycosylation pattern, but did not affect internalization or degradation of CXCR4 in the absence of its ligand CXCL12. Synchronized release of CXCR4 from the endoplasmic reticulum revealed that CMTM4 slowed CXCR4 trafficking from the endoplasmic reticulum to the plasma membrane without affecting overall cell surface expression. Altered CXCR4 trafficking reduced ligand-induced CXCR4 degradation and affected AKT but not ERK1/2 activation. CMTM4 expression, in contrast to that of CXCR4, correlated with the survival of patients with renal cell cancer in the TCGA cohort. Furthermore, we observed that depletion promotes the separation of cells from the pLLP cell cluster in zebrafish embryos. Collectively, our findings indicate that CMTM4 exerts general roles in the biosynthetic pathway of cell surface molecules and seems to affect CXCR4-dependent cell migration.

摘要

MARVEL 蛋白 CMTM4 和 CMTM6 控制 PD-L1,从而影响肿瘤免疫。我们发现,缺陷型斑马鱼通过改变跨后外侧线原基(pLLP)的 Cxcr4b 梯度,减缓了后外侧线(pLL)的发育。在哺乳动物细胞中的分析揭示了 CMTM4 与 CXCR4 相互作用,改变了其糖基化模式,但在没有其配体 CXCL12 的情况下,不影响 CXCR4 的内化或降解。CXCR4 从内质网同步释放表明 CMTM4 减缓了 CXCR4 从内质网到质膜的运输,而不影响总体细胞表面表达。改变的 CXCR4 运输减少了配体诱导的 CXCR4 降解,并影响了 AKT 但不影响 ERK1/2 激活。CMTM4 的表达与 TCGA 队列中肾细胞癌患者的存活相关,与 CXCR4 的表达相反。此外,我们观察到 CMTM4 耗竭促进了斑马鱼胚胎中 pLLP 细胞簇中细胞的分离。总之,我们的研究结果表明,CMTM4 在细胞表面分子的生物合成途径中发挥着普遍作用,似乎影响了 CXCR4 依赖性细胞迁移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/c6e8ef09c8ac/mbc-33-ar116-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/736ced8fa581/mbc-33-ar116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/7c82dfb88f5f/mbc-33-ar116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/bf5294d01890/mbc-33-ar116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/7c2b8c187375/mbc-33-ar116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/61b5e3ae5c86/mbc-33-ar116-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/87a46150e5b8/mbc-33-ar116-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/6cace8f79ad2/mbc-33-ar116-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/d67f1516b68b/mbc-33-ar116-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/c6e8ef09c8ac/mbc-33-ar116-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/736ced8fa581/mbc-33-ar116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/7c82dfb88f5f/mbc-33-ar116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/bf5294d01890/mbc-33-ar116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/7c2b8c187375/mbc-33-ar116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/61b5e3ae5c86/mbc-33-ar116-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/87a46150e5b8/mbc-33-ar116-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/6cace8f79ad2/mbc-33-ar116-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/d67f1516b68b/mbc-33-ar116-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2729/9634968/c6e8ef09c8ac/mbc-33-ar116-g009.jpg

相似文献

1
MARVEL domain containing CMTM4 affects CXCR4 trafficking.MARVEL 结构域包含的 CMTM4 会影响 CXCR4 的转运。
Mol Biol Cell. 2022 Nov 1;33(13):ar116. doi: 10.1091/mbc.E22-05-0152. Epub 2022 Aug 31.
2
CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment.CMTM6 和 CMTM4 作为 PD-L1 的两个新型调节因子调节肿瘤微环境。
Front Immunol. 2022 Jul 25;13:971428. doi: 10.3389/fimmu.2022.971428. eCollection 2022.
3
Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma.CMTM4 在肝细胞癌中的预后意义和免疫特征。
BMC Cancer. 2022 Aug 19;22(1):905. doi: 10.1186/s12885-022-09999-y.
4
Gβ1 controls collective cell migration by regulating the protrusive activity of leader cells in the posterior lateral line primordium.Gβ1 通过调节后外侧线原基中先导细胞的伸出活性来控制细胞的集体迁移。
Dev Biol. 2014 Jan 15;385(2):316-27. doi: 10.1016/j.ydbio.2013.10.027. Epub 2013 Nov 4.
5
CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.CMTM4 调控头颈部鳞状细胞癌中的上皮-间充质转化和 PD-L1 表达。
Mol Carcinog. 2021 Aug;60(8):556-566. doi: 10.1002/mc.23323. Epub 2021 Jun 1.
6
The clinical and prognostic significance of CMTM6/PD-L1 in oncology.CMTM6/PD-L1 在肿瘤学中的临床和预后意义。
Clin Transl Oncol. 2022 Aug;24(8):1478-1491. doi: 10.1007/s12094-022-02811-0. Epub 2022 Mar 12.
7
Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.CMTM4 抑制通过 PD-L1 增强胆管癌和肝细胞癌对 T 细胞介导的抗肿瘤免疫。
Hepatol Commun. 2022 Jan;6(1):178-193. doi: 10.1002/hep4.1682. Epub 2021 Jul 21.
8
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators.鉴定CMTM6和CMTM4为程序性死亡受体配体1(PD-L1)蛋白调节剂。
Nature. 2017 Sep 7;549(7670):106-110. doi: 10.1038/nature23669. Epub 2017 Aug 16.
9
Essential requirement for zebrafish anosmin-1a in the migration of the posterior lateral line primordium.斑马鱼anosmin-1a在后侧线原基迁移中的基本需求。
Dev Biol. 2008 Aug 15;320(2):469-79. doi: 10.1016/j.ydbio.2008.06.008. Epub 2008 Jun 13.
10
CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer.CMTM4 通过 AKT、ERK1/2 和 STAT3 通路抑制结直肠癌细胞增殖和迁移。
Acta Biochim Biophys Sin (Shanghai). 2019 Sep 6;51(9):915-924. doi: 10.1093/abbs/gmz084.

引用本文的文献

1
CMTM4 is an adhesion modulator that regulates skeletal patterning and primary mesenchyme cell migration in sea urchin embryos.CMTM4是一种黏附调节因子,可调节海胆胚胎中的骨骼模式形成和初级间充质细胞迁移。
Dev Biol. 2025 May;521:85-95. doi: 10.1016/j.ydbio.2025.02.009. Epub 2025 Feb 11.

本文引用的文献

1
Golgi Apparatus Regulates Plasma Membrane Composition and Function.高尔基器调节质膜的组成和功能。
Cells. 2022 Jan 22;11(3):368. doi: 10.3390/cells11030368.
2
The significance of the SDF-1/CXCR4 signaling pathway in the normal development.SDF-1/CXCR4 信号通路在正常发育中的意义。
Mol Biol Rep. 2022 Apr;49(4):3307-3320. doi: 10.1007/s11033-021-07069-3. Epub 2022 Jan 24.
3
The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer.CXCL12/CXCR4/CXCR7趋化因子轴在癌症中的作用
Front Pharmacol. 2020 Dec 8;11:574667. doi: 10.3389/fphar.2020.574667. eCollection 2020.
4
CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value.CMTM 家族蛋白 1-8:在癌症生物学过程中的作用及潜在临床价值。
Cancer Biol Med. 2020 Aug 15;17(3):528-542. doi: 10.20892/j.issn.2095-3941.2020.0032.
5
Heterologous regulation of CXCR4 lysosomal trafficking.CXCR4 溶酶体运输的异源调节。
J Biol Chem. 2019 May 17;294(20):8023-8036. doi: 10.1074/jbc.RA118.005991. Epub 2019 Apr 1.
6
Synchronizing Protein Traffic to the Primary Cilium.使蛋白质运输与初级纤毛同步。
Front Genet. 2019 Mar 8;10:163. doi: 10.3389/fgene.2019.00163. eCollection 2019.
7
Glycosylation in health and disease.糖基化在健康和疾病中的作用。
Nat Rev Nephrol. 2019 Jun;15(6):346-366. doi: 10.1038/s41581-019-0129-4.
8
Endocytosis is required for CC chemokine receptor type 4 (CXCR4)-mediated Akt activation and antiapoptotic signaling.内吞作用是 CC 趋化因子受体 4(CXCR4)介导的 Akt 激活和抗凋亡信号所必需的。
J Biol Chem. 2018 Jul 20;293(29):11470-11480. doi: 10.1074/jbc.RA118.001872. Epub 2018 Jun 13.
9
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity.CMTM6维持程序性死亡受体配体1(PD-L1)的表达并调节抗肿瘤免疫。
Nature. 2017 Sep 7;549(7670):101-105. doi: 10.1038/nature23643. Epub 2017 Aug 16.
10
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators.鉴定CMTM6和CMTM4为程序性死亡受体配体1(PD-L1)蛋白调节剂。
Nature. 2017 Sep 7;549(7670):106-110. doi: 10.1038/nature23669. Epub 2017 Aug 16.